Correction: An earlier version of this story incorrectly stated that Shea McCarthy was speaking on behalf of PIPC. Longtime Democratic operative Chris Jennings has joined the governance board of the Institute for Clinical and Economic Review, an independent organization that assesses drug values and that could become a key part of Democrats’ plan to control drug prices. The debate over value assessments is heating up because Democrats are poised to take a run at drug pricing legislation...